IBDEI01I ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,982,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,982,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,983,0)
 ;;=G82.20^^6^75^11
 ;;^UTILITY(U,$J,358.3,983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,983,1,3,0)
 ;;=3^Paraplegia,Unspec
 ;;^UTILITY(U,$J,358.3,983,1,4,0)
 ;;=4^G82.20
 ;;^UTILITY(U,$J,358.3,983,2)
 ;;=^5004125
 ;;^UTILITY(U,$J,358.3,984,0)
 ;;=R53.81^^6^75^9
 ;;^UTILITY(U,$J,358.3,984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,984,1,3,0)
 ;;=3^Malaise,Other
 ;;^UTILITY(U,$J,358.3,984,1,4,0)
 ;;=4^R53.81
 ;;^UTILITY(U,$J,358.3,984,2)
 ;;=^5019518
 ;;^UTILITY(U,$J,358.3,985,0)
 ;;=I69.91^^6^75^3
 ;;^UTILITY(U,$J,358.3,985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,985,1,3,0)
 ;;=3^Cognitive Deficits Following Unspec CVD
 ;;^UTILITY(U,$J,358.3,985,1,4,0)
 ;;=4^I69.91
 ;;^UTILITY(U,$J,358.3,985,2)
 ;;=^5007552
 ;;^UTILITY(U,$J,358.3,986,0)
 ;;=I69.920^^6^75^2
 ;;^UTILITY(U,$J,358.3,986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,986,1,3,0)
 ;;=3^Aphasia Following Unspec CVD
 ;;^UTILITY(U,$J,358.3,986,1,4,0)
 ;;=4^I69.920
 ;;^UTILITY(U,$J,358.3,986,2)
 ;;=^5007553
 ;;^UTILITY(U,$J,358.3,987,0)
 ;;=I69.921^^6^75^4
 ;;^UTILITY(U,$J,358.3,987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,987,1,3,0)
 ;;=3^Dysphasia Following Unspec CVD
 ;;^UTILITY(U,$J,358.3,987,1,4,0)
 ;;=4^I69.921
 ;;^UTILITY(U,$J,358.3,987,2)
 ;;=^5007554
 ;;^UTILITY(U,$J,358.3,988,0)
 ;;=I69.928^^6^75^13
 ;;^UTILITY(U,$J,358.3,988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,988,1,3,0)
 ;;=3^Speech/Lang Deficits Following Unspec CVD
 ;;^UTILITY(U,$J,358.3,988,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,988,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,989,0)
 ;;=I69.951^^6^75^5
 ;;^UTILITY(U,$J,358.3,989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,989,1,3,0)
 ;;=3^Hemiplegia & Hemiparesis Following CVD,Right Dominant Side
 ;;^UTILITY(U,$J,358.3,989,1,4,0)
 ;;=4^I69.951
 ;;^UTILITY(U,$J,358.3,989,2)
 ;;=^5007561
 ;;^UTILITY(U,$J,358.3,990,0)
 ;;=I69.952^^6^75^6
 ;;^UTILITY(U,$J,358.3,990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,990,1,3,0)
 ;;=3^Hemiplegia & Hemiparesis Following CVD,Left Dominant Side
 ;;^UTILITY(U,$J,358.3,990,1,4,0)
 ;;=4^I69.952
 ;;^UTILITY(U,$J,358.3,990,2)
 ;;=^5133586
 ;;^UTILITY(U,$J,358.3,991,0)
 ;;=I69.953^^6^75^7
 ;;^UTILITY(U,$J,358.3,991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,991,1,3,0)
 ;;=3^Hemiplegia & Hemiparesis Following CVD,Right Nondomiant Side
 ;;^UTILITY(U,$J,358.3,991,1,4,0)
 ;;=4^I69.953
 ;;^UTILITY(U,$J,358.3,991,2)
 ;;=^5007562
 ;;^UTILITY(U,$J,358.3,992,0)
 ;;=I69.954^^6^75^8
 ;;^UTILITY(U,$J,358.3,992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,992,1,3,0)
 ;;=3^Hemiplegia & Hemiparesis Following CVD,Left Nondomiant Side
 ;;^UTILITY(U,$J,358.3,992,1,4,0)
 ;;=4^I69.954
 ;;^UTILITY(U,$J,358.3,992,2)
 ;;=^5133587
 ;;^UTILITY(U,$J,358.3,993,0)
 ;;=K21.9^^6^76^4
 ;;^UTILITY(U,$J,358.3,993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,993,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,993,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,993,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,994,0)
 ;;=K21.0^^6^76^3
 ;;^UTILITY(U,$J,358.3,994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,994,1,3,0)
 ;;=3^GERD w/ Esophagitis
 ;;^UTILITY(U,$J,358.3,994,1,4,0)
 ;;=4^K21.0
 ;;^UTILITY(U,$J,358.3,994,2)
 ;;=^5008504
 ;;^UTILITY(U,$J,358.3,995,0)
 ;;=N40.0^^6^76^2
 ;;^UTILITY(U,$J,358.3,995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,995,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,995,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,995,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,996,0)
 ;;=B35.1^^6^76^5
 ;;^UTILITY(U,$J,358.3,996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,996,1,3,0)
 ;;=3^Tinea Unguium
 ;;^UTILITY(U,$J,358.3,996,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,996,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,997,0)
 ;;=R54.^^6^76^1
 ;;^UTILITY(U,$J,358.3,997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,997,1,3,0)
 ;;=3^Age-related Physical Debility
 ;;^UTILITY(U,$J,358.3,997,1,4,0)
 ;;=4^R54.
 ;;^UTILITY(U,$J,358.3,997,2)
 ;;=^5019521
 ;;^UTILITY(U,$J,358.3,998,0)
 ;;=J44.9^^6^77^2
 ;;^UTILITY(U,$J,358.3,998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,998,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,998,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,998,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,999,0)
 ;;=J45.909^^6^77^1
 ;;^UTILITY(U,$J,358.3,999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,999,1,3,0)
 ;;=3^Asthma,Uncomplicated,Unspec
 ;;^UTILITY(U,$J,358.3,999,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,999,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,1000,0)
 ;;=F02.81^^6^78^11
 ;;^UTILITY(U,$J,358.3,1000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1000,1,3,0)
 ;;=3^Dementia in Oth Diseases Classd Elswhr w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,1000,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,1000,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,1001,0)
 ;;=F02.80^^6^78^12
 ;;^UTILITY(U,$J,358.3,1001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1001,1,3,0)
 ;;=3^Dementia in Oth Diseases Classd Elswhr w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,1001,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,1001,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,1002,0)
 ;;=F03.91^^6^78^13
 ;;^UTILITY(U,$J,358.3,1002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1002,1,3,0)
 ;;=3^Dementia w/ Behav Disturb,Unspec
 ;;^UTILITY(U,$J,358.3,1002,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,1002,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,1003,0)
 ;;=G31.83^^6^78^14
 ;;^UTILITY(U,$J,358.3,1003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1003,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,1003,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,1003,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,1004,0)
 ;;=F03.90^^6^78^15
 ;;^UTILITY(U,$J,358.3,1004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1004,1,3,0)
 ;;=3^Dementia w/o Behav Disturb,Unspec
 ;;^UTILITY(U,$J,358.3,1004,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,1004,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,1005,0)
 ;;=F01.51^^6^78^30
 ;;^UTILITY(U,$J,358.3,1005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1005,1,3,0)
 ;;=3^Vascular Dementia w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,1005,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,1005,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,1006,0)
 ;;=F01.50^^6^78^31
 ;;^UTILITY(U,$J,358.3,1006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1006,1,3,0)
 ;;=3^Vascular Dementia w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,1006,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,1006,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,1007,0)
 ;;=A81.9^^6^78^6
 ;;^UTILITY(U,$J,358.3,1007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1007,1,3,0)
 ;;=3^Atypical Virus Infection of CNS,Unspec
 ;;^UTILITY(U,$J,358.3,1007,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,1007,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,1008,0)
 ;;=A81.09^^6^78^8
 ;;^UTILITY(U,$J,358.3,1008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1008,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease NEC
 ;;^UTILITY(U,$J,358.3,1008,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,1008,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,1009,0)
 ;;=A81.00^^6^78^9
 ;;^UTILITY(U,$J,358.3,1009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1009,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,1009,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,1009,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,1010,0)
 ;;=A81.01^^6^78^10
 ;;^UTILITY(U,$J,358.3,1010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1010,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,1010,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,1010,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,1011,0)
 ;;=A81.89^^6^78^7
 ;;^UTILITY(U,$J,358.3,1011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1011,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
